Clinical Updates in Cystic Fibrosis-Related Diabetes Learn more about cystic fibrosis-related diabetes, the commonest extrapulmonary complication of cystic fibrosis. Seminars in Respiratory and ...

The Clinical and Translational Core, established at our Center in 1999, provides necessary resources and expertise to provide these capabilities for a wide variety of CF scientists, significantly ...

Discover how poor sleep quality significantly increases malnutrition risk in adolescents with cystic fibrosis. Learn why ...

Patients aged 6 to 11 years with cystic fibrosis receiving 24-week once-daily vanzacaftor/tezacaftor/deutivacaftor generally ...

Sionna Therapeutics aims to raise $100 million in an IPO for cystic fibrosis drugs, backed by venture capital, targeting a ...

No single score captures the burden of treatment in people with cystic fibrosis (pwCF), according to systematic review study findings published in the Journal of Cystic Fibrosis.

Collaborative Discovery Programme (CDP) funding introduced by the Cystic Fibrosis Antimicrobial Resistance (CF AMR) Syndicate ...

Credit: Vertex. According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment. An additional 94 non-F508del CFTR mutations and a boxed ...

The UAB ILD Center offers clinical trial enrollment for patients with idiopathic pulmonary fibrosis and other forms of diffuse parenchymal lung disease as part of a multidisciplinary and integrated ...

Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.

The Baylor Medicine Maconda Brown O'Connor, Ph.D., Adult Cystic Fibrosis Center provides the highest quality care in a compassionate, patient-centered setting. Our center, which is accredited by the ...